Thailand's second domestically developed vaccine will soon undergo human trials, officials said on Thursday, adding that the plan was to produce up to five million doses by the end of the year.

The vaccine, developed by Thailand's Chulalongkorn University, had success in trials in mice and monkeys and is due to be tested on humans in late April or early May, Kiat Ruxrungtham of the Chula Vaccine Research Center said...